Relationship of plasma catecholamines to blood pressure in hypertensive patients during beta-adrenoceptor blockade with and without intrinsic sympathomimetic activity.

This publication has 18 references indexed in Scilit:

• Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
  British Journal of Clinical Pharmacology, 1980
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity
  American Heart Journal, 1979
• Increased catecholamine excretion after labetalol therapy: A spurious effect of drug metabolites
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1979
• Studies on the effects of propranolol on plasma catecholamine levels in patients with essential hypertension
  European Journal of Clinical Investigation, 1978
• Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease: plasma noradrenaline splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise
  European Journal of Clinical Investigation, 1978
• Interference with fluorimetric assay of catecholamine by labetalol.
  The Tohoku Journal of Experimental Medicine, 1978
• Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine
  Life Sciences, 1977
• Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate.
  Circulation Research, 1976
• Effects of β adrenergic blockade on plasma catecholamines in exercise
  Nature, 1974
• Haemodynamic effects of beta-adrenergic blockade.
  Heart, 1968